{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:22:27Z","timestamp":1788909747037,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G\u2009&gt;\u2009A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24\u2009months during supplementation with coenzyme Q10 (20\u2009mg\/kg\/d \u2013 30\u2009mg\/kg\/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient\u2019s urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-020-02208-7","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:05:28Z","timestamp":1610031928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangzhe","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"6255","key":"2208_CR1","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1126\/science.aac7516","volume":"349","author":"RN Lightowlers","year":"2015","unstructured":"Lightowlers RN, Taylor RW, Turnbull DM. Mutations causing mitochondrial disease: what is new and what challenges remain? Science. 2015;349(6255):1494\u20139.","journal-title":"Science"},{"key":"2208_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurol.2016.07.003","volume":"172","author":"C Tranchant","year":"2016","unstructured":"Tranchant C, Anheim M. Movement disorders in mitochondrial diseases. Rev Neurol (Paris). 2016;172:524\u20139.","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"2208_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1159\/000013406","volume":"18","author":"F Kurogouchi","year":"1998","unstructured":"Kurogouchi F, Oguchi T, Mawatari E, Yamaura S, Hora K, Takei M, et al. A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am J Nephrol. 1998;18(6):551\u20136.","journal-title":"Am J Nephrol"},{"issue":"12","key":"2208_CR4","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1172\/JCI69000","volume":"123","author":"S Ashraf","year":"2013","unstructured":"Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013;123(12):5179\u201389.","journal-title":"J Clin Invest"},{"issue":"1","key":"2208_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1681\/ASN.2014121240","volume":"27","author":"E Korkmaz","year":"2016","unstructured":"Korkmaz E, Lipska-Zietkiewicz BS, Boyer O, Gribouval O, Fourrage C, Tabatabaei M, et al. ADCK4-associated Glomerulopathy causes adolescence-onset FSGS. J Am Soc Nephrol. 2016;27(1):63\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"47","key":"2208_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008880","volume":"96","author":"C Feng","year":"2017","unstructured":"Feng C, Wang Q, Wang J, Liu F, Shen H, Fu H, et al. Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: case reports and literature review. Medicine (Baltimore). 2017;96(47):e8880.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2208_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bbrc.2018.10.102","volume":"506","author":"J Yang","year":"2018","unstructured":"Yang J, Yang Y, Hu Z. A novel ADCK4 mutation in a Chinese family with ADCK4-associated glomerulopathy. Biochem Biophys Res Commun. 2018;506(3):444\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2208_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/biof.155","volume":"37","author":"CM Quinzii","year":"2011","unstructured":"Quinzii CM, Hirano M. Primary and secondary CoQ (10) deficiencies in humans. Biofactors. 2011;37(5):361\u20135.","journal-title":"Biofactors"},{"issue":"1","key":"2208_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","volume":"38","author":"MA Desbats","year":"2015","unstructured":"Desbats MA, Lunardi G, Doimo M, Trevisson E, Salviati L. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency. J Inherit Metab Dis. 2015;38(1):145\u201356.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"2208_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-017-3590-y","volume":"32","author":"F Wang","year":"2017","unstructured":"Wang F, Zhang Y, Mao J, Yu Z, Yi Z, Yu L, et al. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2017;32(7):1181\u201392.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2208_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/jcm6040037","volume":"6","author":"D Yubero","year":"2017","unstructured":"Yubero D, Allen G, Artuch R, Montero R. The value of coenzyme Q10 determination in mitochondrial patients. J Clin Med. 2017;6(4):37.","journal-title":"J Clin Med"},{"issue":"12","key":"2208_CR12","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00467-018-4083-3","volume":"33","author":"M Sta\u0144czyk","year":"2018","unstructured":"Sta\u0144czyk M, Ba\u0142asz-Chmielewska I, Lipska-Zi\u0119tkiewicz B, Tkaczyk MJP. CoQ10-related sustained remission of proteinuria in a child with COQ6 glomerulopathy-a case report. Pediatr Nephrol. 2018;33(12):2383\u20137.","journal-title":"Pediatr Nephrol"},{"key":"2208_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/biof.5520090205","volume":"9","author":"T Nakamura","year":"1999","unstructured":"Nakamura T, Ohno T, Hamamura K, Sato TJB. Metabolism of coenzyme Q10: biliary and urinary excretion study in Guinea pigs. Biofactors. 1999;9:111\u20139.","journal-title":"Biofactors"},{"issue":"9","key":"2208_CR14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00467-017-3657-9","volume":"32","author":"E Park","year":"2017","unstructured":"Park E, Kang HG, Choi YH, Lee KB, Moon KC, Jeong HJ, et al. Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations. Pediatr Nephrol. 2017;32(9):1547\u201354.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2208_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12881-017-0392-9","volume":"18","author":"K Lolin","year":"2017","unstructured":"Lolin K, Chiodini BD, Hennaut E, Adams B, Dahan K, Ismaili K. Early-onset of ADCK4 glomerulopathy with renal failure: a case report. BMC Med Genet. 2017;18(1):28.","journal-title":"BMC Med Genet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-02208-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:25:51Z","timestamp":1610033151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02208-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02208-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants involved in the study and the study was approved by the Institute\u2019s Committee of Xiangya hospital, Central South University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient of the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}